India doubling time 8 days (National), 7 days Maharashtra and 19 days Kerala
India
healthysoch
New Delhi, April 19, 2020 :
210 Countries, over 2.33 M cases, Deaths crosses 175,000, with minimum expected deaths over 169045, around 6000 deaths per day, 20.6 deaths per million population
US:
9,282 health care workers
723 Hospitalisation
27 deaths
1st 100,000 in 67 days, 2nd in 11 days, 3rd in 4 days, 4th in 3-day, 5th in 2.5 Days, 6th in 2 days, 7th in 2 days, and subsequent in 1.5 days
First reported Case: 10th January
Situation Around the Globe
Likely minimum deaths (160755 + 55265 x 15 = 8290) = 169045
Cases: 2,330,937 (81287 yesterday)
Deaths: 160,755 (6505 yesterday)
Recovered: 596,537
ACTIVE CASES: 1,573,645
Currently Infected Patients
Mild 1,518,380 (96%)
Serious: 55,265 (4%)
CLOSED CASES: 757,292
Recovered: 596,537 (79%)
Deaths: 160755
Cases per million population (global) 299
Deaths per million population (global) 20.6
India
Confirmed 15,722
Deaths: 521
Recovered: 2,463
CLOSED CASES: 2,984
Cases which had an outcome:
2,463 (83%) Recovered / Discharged
521 (17%) Deaths
Cases: 11 per million population
0.4 deaths per million population
243 tests per million population
India Cases on 18th 15722 Case on 10th April 7600,11th April 8446 Doubling time: 8.5 days
Lower doubling times needs more attention MP, Gujarat
Growth factor > 1
GF = every day’s new cases / new cases on the previous day. For example, a quantity growing by 7% every period (in this case daily) has a growth factor of 1.07. A growth factor above 1 indicates an increase, whereas one which remains between 0 and 1 it is a sign of decline, with the quantity eventually becoming zero, whereas a growth factor constantly above 1 could signal exponential growth.
Death Rate :
Europe 10% [100,000 deaths with 1 million cases]
Asia 3.89% [ 370166 cases and 14401 deaths)
Oceania 1.05% [8105 cases and 85 deaths]
North America: 5.26% [792066 cases and 41641 deaths]
Africa: 4.98% [21741 cases with 1082 deaths]
South America: 4.7% [78042 cases with 3661 deaths]
India 3.31% [15722 cases with 521 deaths]
World 6.9% [2330937 cases with 160755 deaths]
Updates :
- 30% of India cases are from Tablighi Jamaat
- Youngest casualty in India: 45 days old admitted at Delhi’s Kalawati Saran Children’s hospital (total 10 cases)
- In one containment zone, in one family in Jahangirpuri 26 people testes positive
- Pandemic is National Health Emergency
- If you are a healthcare worker and on HCQS prophylaxis fill the form https://www.surveymonkey.com/r/6KPW8CR
- India doubling time is > 8 days
- Open health care establishments all across now
- Treat every surface and asymptomatic person as virus carrier
- COVID 19 may assume a seasonal nature.
- BCG may be protecting Indians to some extent. ICMR has started a study. Cases 11 per million population against 299 global
- Diagnose early (antibodies test will take 7 days to detect) and treat early (reduce viral load and prevent cytokine storm)
- The WHO issued a warning that there’s no evidence that serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected.Nobody is sure whether someone with antibodies is fully protected against having the disease or being exposed again. Tests also may give a false negative result.
- WHO said not all people who recover from the coronavirus have the antibodies to fight a second infection? With regards to recovery and then reinfection we do not have the answer yet.
- A preliminary study of patients in Shanghai found that some patients had “no detectable antibody response” while others had a very high response. Whether the patients who had a strong antibody response were immune to a second infection is “a separate unknown question”.
- Both ARDS and silent hypoxia requires specific non ventilatory and ventilatory prone settings with standby ECMO. tPA, heparin, ACE inhibitors, early treatment, plasma therapy, blood/ cord blood transfusion, timely air lift of critical patients may help.
- Post @ https://mobile.twitter.com/ChestImaging?s=08: Post COVID positive X rays, CT images. Normal chest X ray does not rule out COVID.
- Collateral benefits: Reduction in air pollution, Clear Ganges, reduction in overall deaths (low pollution, less stress, more hygiene, no traffic accident deaths).
- ZIKA Brazil Model: Army used for the crisis. Keep Army at standby
- Quarantine models
India: Early lock down for forty days
Wuhan: Selective sealing of epicentre
Vietnam: Sealing of a village with most cases
Bhilwara CLUSTER: Seal 2 km all around, fumigate each house, house to house survey for ALI and SARI, isolate infected cases, test all close contacts
Bird flu model: April 20, 2016, the Lebanonese Ministry of Agriculture found H5N1 in 2 poultry farms in the border of Lebanon with Syria. 20,000 domestic birds died. The ministry culled all (60K) domestic birds within a 3-km radius. All farms were disinfected, and organic remains were disposed safely.
Germany, Sweden and Japan model: Selective isolation of elderly and high-risk comorbid patients
S Korea: Intensify testing amongst all or high-risk group
Italy: Deploy younger health care workers and women as front-line fighters (2 hospitals posted young doctors < 40 years, 60% women on duties with no mortality in healthcare workers)
Singapore: Make available surgical masks at reception to be worn by all patients entering the hospital. Give N 95 masks to all health care providers and use AII rooms for all procedures on infected cases
- Convalescent plasm therapy: India, USA started it. Reduces viral load
- Protect healthcare workers:Delhi HCW model: Keep all the healthcare workers on duty in hotels
- Significant exposure to Covid-19: face-to-face contact within 6 feet with a patient with symptomatic Covid-19 that is sustained for at least a few minutes (and some say more than 10 minutes or even 30 minutes). The chance of catching Covid-19 from a passing interaction in a public space is minimal.
- Mask Policy: All health workers in health care setting should wear N 95/ surgical and general public should wear cloth mask when on the roads.
- Market: The cost of API used in hydroxychloroquine has touched around Rs 70,000 per kg, from around Rs 6,500 per kg in February. The cost of API for azithromycin, the other drug used in combination with hydroxychloroquine for treating coronavirus, have doubled to Rs 16,000 a kg. China is a major supplier of APIs.
- A six-day delay by China costed the whole world:On January 14, top Chinese officials sensed a pandemic. The head of China’s National Health Commission, Ma Xiaowei, in a confidential teleconference with provincial health officials, said: “The epidemic situation is still severe and complex, the most severe challenge since SARS in 2003, and is likely to develop into a major public health event.” Yet in the six days that followed, Wuhan hosted a banquet attended by thousands and millions of Chinese migrated within the country for the Lunar New Year celebrations. On January 20, President Xi Jinping warned the public, saying the outbreak “must be taken seriously”. The same day, a leading Chinese epidemiologist, Zhong Nanshan, announced for the first time that the virus was transmissible from person to person on national television. But by then, more than 3,000 people had been infected.
- 12 days of silence added to the fuel:From Jan. 5 to Jan. 17, China’s Center for Disease Control did not register any case of pneumonia-like disease from local officials. Yet during that time, hundreds of patients were appearing in hospitals not just in Wuhan but across the country. On January 2, local officials of the Chinese Communist Party punished eight doctors for “rumour mongering” for warning friends on social media about the emerging SARS-like threat. One of the doctors, Dr. Li Wenliang, later died on Feb. 7.
- The two Chinese companies sold UK 2 M home test kits said to detect antibodies for the coronavirus for $20 million paid upfront on take it or leave it terms. The simple pregnancy test like option was a potential game changer but the tests did not work.
- Rota virus, polio and measles should not be ignored in this season
| Country, Other |
Total Cases |
New Cases |
Total Deaths |
New Deaths |
Total Recovered |
Active Cases |
Serious, Critical |
Tot Cases/ 1M pop |
Deaths/ 1M pop |
Total Tests |
Tests/ 1M pop |
| World | 2,330,937 | +787 | 160,755 | +112 | 596,537 | 1,573,645 | 55,265 | 299 | 20.6 | ||
| USA | 738,830 | +38 | 39,014 | 68,285 | 631,531 | 13,551 | 2,232 | 118 | 3,722,209 | 11,245 | |
| Spain | 194,416 | 20,639 | 74,797 | 98,980 | 7,371 | 4,158 | 441 | 930,230 | 19,896 | ||
| Italy | 175,925 | 23,227 | 44,927 | 107,771 | 2,733 | 2,910 | 384 | 1,305,833 | 21,598 | ||
| France | 151,793 | 19,323 | 35,983 | 96,487 | 5,833 | 2,325 | 296 | 463,662 | 7,103 | ||
| Germany | 143,724 | 4,538 | 85,400 | 53,786 | 2,922 | 1,715 | 54 | 1,728,357 | 20,629 | ||
| UK | 114,217 | 15,464 | N/A | 98,409 | 1,559 | 1,682 | 228 | 460,437 | 6,783 | ||
| China | 82,735 | +16 | 4,632 | 77,062 | 1,041 | 85 | 57 | 3 | |||
| Turkey | 82,329 | 1,890 | 10,453 | 69,986 | 1,894 | 976 | 22 | 598,933 | 7,101 | ||
| Iran | 80,868 | 5,031 | 55,987 | 19,850 | 3,513 | 963 | 60 | 330,137 | 3,931 | ||
| Belgium | 37,183 | 5,453 | 8,348 | 23,382 | 1,119 | 3,208 | 471 | 145,997 | 12,597 | ||
| Russia | 36,793 | 313 | 3,057 | 33,423 | 8 | 252 | 2 | 1,831,892 | 12,553 | ||
| Brazil | 36,760 | +38 | 2,368 | +7 | 14,026 | 20,366 | 6,634 | 173 | 11 | 62,985 | 296 |
| Canada | 33,383 | 1,470 | 11,207 | 20,706 | 557 | 885 | 39 | 516,216 | 13,677 | ||
| Netherlands | 31,589 | 3,601 | 250 | 27,738 | 1,279 | 1,844 | 210 | 154,911 | 9,041 | ||
| Switzerland | 27,404 | 1,368 | 17,100 | 8,936 | 386 | 3,166 | 158 | 216,400 | 25,004 | ||
| Portugal | 19,685 | 687 | 610 | 18,388 | 228 | 1,931 | 67 | 235,878 | 23,133 | ||
| India | 15,722 | 521 | 2,463 | 12,738 | 11 | 0.4 | 335,123 | 243 | |||
| Ireland | 14,758 | 571 | 77 | 14,110 | 294 | 2,989 | 116 | 90,646 | 18,358 | ||
| Austria | 14,671 | 443 | 10,214 | 4,014 | 208 | 1,629 | 49 | 175,932 | 19,534 | ||
| Peru | 14,420 | 348 | 6,684 | 7,388 | 117 | 437 | 11 | 135,895 | 4,122 | ||
| Sweden | 13,822 | 1,511 | 550 | 11,761 | 1,054 | 1,369 | 150 | 74,600 | 7,387 | ||
| Israel | 13,265 | 164 | 3,456 | 9,645 | 164 | 1,533 | 19 | 187,250 | 21,634 | ||
| S. Korea | 10,653 | 232 | 7,937 | 2,484 | 55 | 208 | 5 | 546,463 | 10,659 |
Author : Dr KK Aggarwal , President CMAAO, HCFI and Past National President IMA